Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
British Journal of Pharmacology|October 20, 2004
Platelet--cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregationPaul Jurasz, David Alonso-Escolano, Marek W RadomskiBritish Journal of Pharmacology|December 24, 2003
Membrane type-1 matrix metalloproteinase stimulates tumour cell-induced platelet aggregation: role of receptor glycoproteinsDavid Alonso-Escolano, Alex Y Strongin, Ada W Chung, et al.Applied Health Economics and Health Policy|September 9, 2008
Cost-effectiveness analysis of switching antipsychotic medication to long-acting injectable risperidone in patients with schizophrenia : a 12- and 24-month follow-up from the e-STAR database in SpainJosé M Olivares, Alfonso Rodriguez-Martinez, José A Burón, et al.CNS Spectrums|May 8, 2010
Adherence to treatment and therapeutic strategies in schizophrenic patients: the ADHERE studyJosé Ramón Gutiérrez-Casares, Fernando Cañas, Alexander Rodríguez-Morales, et al.British Journal of Pharmacology|September 15, 2005
Nanoparticle-induced platelet aggregation and vascular thrombosisAnna Radomski, Paul Jurasz, David Alonso-Escolano, et al.British Journal of Pharmacology|November 10, 2004
Platelet-leukocyte aggregation induced by PAR agonists: regulation by nitric oxide and matrix metalloproteinasesAda W Y Chung, Anna Radomski, David Alonso-Escolano, et al.Cerebrovascular Diseases (Basel, Switzerland)|May 3, 2006
Neurorepair versus neuroprotection in strokeOlivia Hurtado, Jesus M Pradillo, David Alonso-Escolano, et al.The Journal of Pharmacology and Experimental Therapeutics|April 18, 2006
Protein kinase C delta mediates platelet-induced breast cancer cell invasionDavid Alonso-Escolano, Carlos Medina, Katarzyna Cieslik, et al.Journal of Neuropathology and Experimental Neurology|September 6, 2005
The nonthiazolidinedione PPARgamma agonist L-796,449 is neuroprotective in experimental strokeMarta P Pereira, Olivia Hurtado, Antonio Cárdenas, et al.Pageof 1